Olagunju Peter's Form 4 filing
TCR2 Therapeutics Inc. (TCRR) · filed Dec 13, 2022
- Accession no.
- 0000899243-22-038384
- Filed
- Dec 13, 2022
- Trade date
- Dec 9-13, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $5.31K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Olagunju PeterCIK 0001875057 | Officer (Chief Technical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 9, 2022 | Common Stock | SSaleDisposed | −1,561 | $1.13 | −$1,763.93 | 27,361 | Direct | |
| Dec 12, 2022 | Common Stock | SSaleDisposed | −1,610 | $1.10 | −$1,771 | 25,751 | Direct | |
| Dec 13, 2022 | Common Stock | SSaleDisposed | −1,659 | $1.07 | −$1,775.13 | 24,092 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.